Meeting Topics

1. Non-coding-RNA activity; diagnostic and therapeutic implications.

2. Biomolecular pathogenesis of cardiovascular, hepatic and metabolic disorders.

3. Oxidative stress; cellular responses and decompensation.

4. Stem cell-based therapeutic strategies; difficulties in clinical applications.

5. Mitochondriopathies; pathophysiology and diagnostic measures.

6. Nanoparticles as therapeutic means for genetic and/or acquired diseases.